- Corporate
- For Print
- October 2, 2026
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announces that it will receive a dividend from its consolidated subsidiary, Eisai Europe Ltd. As this matter falls under the requirement for submission of an Extraordinary Report pursuant to the provisions of Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and Article 19, Paragraph 2, Item 12 of the Cabinet Office Order on Disclosure of Corporate Affairs, the details are as follows.
1. Summary of dividend
(1) Dividend Amount ：GBP 150 million（approximately JPY 31.2 billion*）
(2) Date of resolution ：October 2, 2026
(3) Expected date of receipt ：Early October 2026
*The amount in Japanese yen is calculated using the following exchange rate: 1 GBP = 208.11 JPY
2. Financial impact
The dividend received will be recorded as non-operating income in Eisai’s non-consolidated financial statements for the fiscal year ending March 31, 2027. Since the dividend is received from a consolidated subsidiary, there will be no impact on the consolidated financial results for the fiscal year ending March 31, 2027.
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
Our news releases are intended to disclose corporate information and are not intended for the promotion or advertising of prescription pharmaceuticals or investigational products, nor are they intended to provide medical advice.
Please note that the information contained in news releases is current as of the date of publication.